Recurrent Mantle Cell Lymphoma Clinical Trials in Columbus

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Active, not recruiting
  • Recurrent Diffuse Large B-Cell Lymphoma
  • +8 more
  • Chicago, Illinois
  • +2 more
2022-04-05
Apr 5, 2022
Y
Suspended
  • Recurrent B-Cell Non-Hodgkin Lymphoma
  • +23 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
2022-02-23
Feb 23, 2022
N
Suspended
  • Recurrent B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma
  • +25 more
  • Birmingham, Alabama
  • +23 more
2022-03-05
Mar 5, 2022
J
Active, not recruiting
  • Prolymphocytic Leukemia
  • +4 more
  • Columbus, Ohio
  • +1 more
2022-02-24
Feb 24, 2022
N
Active, not recruiting
  • Recurrent Mantle Cell Lymphoma
  • Saint Louis, Missouri
  • +3 more
2022-02-12
Feb 12, 2022
K
Active, not recruiting
  • Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
  • +8 more
  • PI3K inhibitor BKM120
  • +3 more
  • Atlanta, Georgia
  • +1 more
2021-09-29
Sep 29, 2021
D
Recruiting
  • Grade 3a Follicular Lymphoma
  • +14 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Atlanta, Georgia
  • +1 more
2021-05-13
May 13, 2021
K
Active, not recruiting
  • Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
  • +9 more
  • BTK inhibitor PCI-32765
  • +5 more
  • Columbus, Ohio
    Ohio State University Medical Center
2021-02-20
Feb 20, 2021
K
Completed
  • B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classical Hodgkin Lymphoma
  • +18 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
2019-07-29
Jul 29, 2019
N
Completed
  • Recurrent Mantle Cell Lymphoma
  • Anaheim, California
  • +81 more
2018-10-02
Oct 2, 2018
O
Terminated
  • Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
  • +10 more
  • Atlanta, Georgia
  • +1 more
2018-05-03
May 3, 2018
A
Completed
  • Adult Nasal Type Extranodal NK/T-cell Lymphoma
  • +66 more
  • Pharmacodynamic Studies
  • +3 more
  • Columbus, Ohio
    The Ohio State University James Cancer Hospital
2018-05-31
May 31, 2018
N
Completed
  • Adult Acute Myeloid Leukemia in Remission
  • +41 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
2017-09-22
Sep 22, 2017
N
Terminated
  • Adult Lymphocyte Depletion Hodgkin Lymphoma
  • +27 more
  • Columbus, Ohio
    Ohio State University Medical Center
2016-06-27
Jun 27, 2016
N
Completed
  • Anaplastic Large Cell Lymphoma
  • +58 more
  • Columbus, Ohio
    Ohio State University Medical Center
2013-09-27
Sep 27, 2013
N
Completed
  • B-cell Adult Acute Lymphoblastic Leukemia
  • +52 more
  • rituximab
  • +3 more
  • Columbus, Ohio
    Ohio State University Medical Center
2013-06-05
Jun 5, 2013
N
Withdrawn
  • Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
  • +6 more
  • bendamustine hydrochloride
  • +2 more
  • Columbus, Ohio
    Arthur G. James Cancer Hospital and Solove Research Institute at
2013-06-05
Jun 5, 2013
N
Completed
  • Recurrent Adult Burkitt Lymphoma
  • +2 more
  • Columbus, Ohio
    Ohio State University Medical Center
2013-06-03
Jun 3, 2013
N
Terminated
  • Adult Acute Basophilic Leukemia
  • +34 more
  • Columbus, Ohio
    Ohio State University Medical Center
2013-06-03
Jun 3, 2013
N
Completed
  • B-cell Chronic Lymphocytic Leukemia
  • +42 more
  • Columbus, Ohio
    Ohio State University Medical Center
2013-06-03
Jun 3, 2013